Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
74.61 EUR | -0.15% |
|
+0.63% | +7.29% |
Jun. 13 | DuPont Launches New Tedlar® Frontsheet Offerings At 2024 Snec Pv Power Expo | CI |
Jun. 07 | Declaration of Voting Results by DuPont de Nemours, Inc | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Sales forecast by analysts have been recently revised upwards.
- For the past twelve months, EPS forecast has been revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company benefits from high valuations in earnings multiples.
- With an enterprise value anticipated at 3.19 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.29% | 33.75B | - | ||
+4.51% | 77.12B | B | ||
-6.64% | 43.09B | A- | ||
+15.37% | 19.01B | B | ||
+9.20% | 11.64B | A- | ||
-4.85% | 9.97B | - | ||
-5.91% | 8.8B | A- | ||
+0.78% | 8.59B | C- | ||
-1.54% | 7.54B | B | ||
-13.07% | 5.64B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DD Stock
- DDPN Stock
- Ratings DuPont de Nemours, Inc.